NCT03102918View on ClinicalTrials.gov

Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 20, 2016

Primary Completion Date

August 30, 2017

Study Completion Date

August 30, 2017

Conditions
Cannabis Use Disorder
Interventions
DRUG

Cannabidiol

Participants will receive either up to 800 mg Epidiolex over a 6-week treatment period.

DRUG

Placebo

Participants will receive placebo over a 6-week treatment period.

Trial Locations (1)

02478

McLean Hospital, Belmont

All Listed Sponsors
lead

Mclean Hospital

OTHER

NCT03102918 - Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder | Biotech Hunter | Biotech Hunter